[
  {
    "ts": null,
    "headline": "Boston Scientific Corporation (BSX) Q4 2024 Earnings Call Transcript",
    "summary": "Boston Scientific Corporation (NYSE:BSX) Q4 2024 Earnings Conference Call February 5, 2025 8:00 AM ETCompany ParticipantsJonathan Monson - SVP, IRMichael...",
    "url": "https://finnhub.io/api/news?id=c21fa033db6cb4178484f755081a776b9aee5f30193a046b30e7b681eba63052",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738755105,
      "headline": "Boston Scientific Corporation (BSX) Q4 2024 Earnings Call Transcript",
      "id": 132563162,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "BSX",
      "source": "SeekingAlpha",
      "summary": "Boston Scientific Corporation (NYSE:BSX) Q4 2024 Earnings Conference Call February 5, 2025 8:00 AM ETCompany ParticipantsJonathan Monson - SVP, IRMichael...",
      "url": "https://finnhub.io/api/news?id=c21fa033db6cb4178484f755081a776b9aee5f30193a046b30e7b681eba63052"
    }
  },
  {
    "ts": null,
    "headline": "How Boston Sci Leaned On Its New Heart Device For A Fourth-Quarter Beat",
    "summary": "How Boston Sci Leaned On Its New Heart Device For A Fourth-Quarter Beat",
    "url": "https://finnhub.io/api/news?id=5656572800f084ba2d578b94aecaf7ff59fc0cccd960a87d373d47ef8e25fb24",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738750745,
      "headline": "How Boston Sci Leaned On Its New Heart Device For A Fourth-Quarter Beat",
      "id": 132566454,
      "image": "",
      "related": "BSX",
      "source": "DowJones",
      "summary": "How Boston Sci Leaned On Its New Heart Device For A Fourth-Quarter Beat",
      "url": "https://finnhub.io/api/news?id=5656572800f084ba2d578b94aecaf7ff59fc0cccd960a87d373d47ef8e25fb24"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific : Interested in our Q4 2024 earnings",
    "summary": "Today, Boston Scientific shared its financial results for the fourth quarter of 2024. Overall, we generated net sales of $4.561 billion during the fourth quarter of 2024, growing 22.4 percent on a...",
    "url": "https://finnhub.io/api/news?id=c238bde9f73fc60c27a3f22e9da04cd36c9679da79539a1c574d5759b0817e09",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738749485,
      "headline": "Boston Scientific : Interested in our Q4 2024 earnings",
      "id": 132562632,
      "image": "",
      "related": "BSX",
      "source": "Finnhub",
      "summary": "Today, Boston Scientific shared its financial results for the fourth quarter of 2024. Overall, we generated net sales of $4.561 billion during the fourth quarter of 2024, growing 22.4 percent on a...",
      "url": "https://finnhub.io/api/news?id=c238bde9f73fc60c27a3f22e9da04cd36c9679da79539a1c574d5759b0817e09"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific sees higher-than-expected 2025 profit on strong demand",
    "summary": "Medical device maker Boston Scientificforecast annual profit above Wall Street estimates onWednesday, banking on steady demand for its heart devices. Manufacturers of medical devices...",
    "url": "https://finnhub.io/api/news?id=8af10416f620e9871d5e815fbd326cdc71c07f228454a13db7c02b1750a2016e",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738742078,
      "headline": "Boston Scientific sees higher-than-expected 2025 profit on strong demand",
      "id": 132561765,
      "image": "",
      "related": "BSX",
      "source": "Finnhub",
      "summary": "Medical device maker Boston Scientificforecast annual profit above Wall Street estimates onWednesday, banking on steady demand for its heart devices. Manufacturers of medical devices...",
      "url": "https://finnhub.io/api/news?id=8af10416f620e9871d5e815fbd326cdc71c07f228454a13db7c02b1750a2016e"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific 4Q Profit Up on Strong Cardio Device Sales",
    "summary": "By Rob Curran Boston Scientific said its fourth-quarter net income rose 12% amid robust demand for its stents, catheters and other cardiology devices. The Marlborough, Mass., medical-device...",
    "url": "https://finnhub.io/api/news?id=e2e13ff3ce97c2dfd00584082df775b97b75f58386b036d12508137df0aa93b6",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738740196,
      "headline": "Boston Scientific 4Q Profit Up on Strong Cardio Device Sales",
      "id": 132560850,
      "image": "",
      "related": "BSX",
      "source": "Finnhub",
      "summary": "By Rob Curran Boston Scientific said its fourth-quarter net income rose 12% amid robust demand for its stents, catheters and other cardiology devices. The Marlborough, Mass., medical-device...",
      "url": "https://finnhub.io/api/news?id=e2e13ff3ce97c2dfd00584082df775b97b75f58386b036d12508137df0aa93b6"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific: Q4 Earnings Snapshot",
    "summary": "MARLBOROUGH, Mass. — MARLBOROUGH, Mass. — Boston Scientific Corp. on Wednesday reported fourth-quarter earnings of $566 million. The Marlborough, Massachusetts-based company said it had net...",
    "url": "https://finnhub.io/api/news?id=8ca80d959f44b0a0a96dfeab084804821acf175c0b60e86dcfb65586c043b956",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738738208,
      "headline": "Boston Scientific: Q4 Earnings Snapshot",
      "id": 132560660,
      "image": "",
      "related": "BSX",
      "source": "Finnhub",
      "summary": "MARLBOROUGH, Mass. — MARLBOROUGH, Mass. — Boston Scientific Corp. on Wednesday reported fourth-quarter earnings of $566 million. The Marlborough, Massachusetts-based company said it had net...",
      "url": "https://finnhub.io/api/news?id=8ca80d959f44b0a0a96dfeab084804821acf175c0b60e86dcfb65586c043b956"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Reports Results For Q4 And FY 2024",
    "summary": "Boston Scientific Corp: * BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR FOURTH QUARTER ANDFULLYEAR 2024 * BOSTON SCIENTIFIC CORP OUTLOOK Q1 ADJUSTED EPS $0.66 TO$0.68VERSUS...",
    "url": "https://finnhub.io/api/news?id=d27310eac0901b846608ed5d1ade6fb2f7ee465ca1dc411e26d224c21290df8f",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738738049,
      "headline": "Boston Scientific Reports Results For Q4 And FY 2024",
      "id": 132560657,
      "image": "",
      "related": "BSX",
      "source": "Finnhub",
      "summary": "Boston Scientific Corp: * BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR FOURTH QUARTER ANDFULLYEAR 2024 * BOSTON SCIENTIFIC CORP OUTLOOK Q1 ADJUSTED EPS $0.66 TO$0.68VERSUS...",
      "url": "https://finnhub.io/api/news?id=d27310eac0901b846608ed5d1ade6fb2f7ee465ca1dc411e26d224c21290df8f"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific : Q4 2024 Financial and Operational Highlights",
    "summary": "Q4 2024 Highlights February 5, 2025 Q4 2024 Financial & Operational Highlights | February 5, 2025 ...",
    "url": "https://finnhub.io/api/news?id=6b78a01feda96b8fc71dad258580033f01de07a54d7dbe6672c0fb6cdf2dbfb0",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738737847,
      "headline": "Boston Scientific : Q4 2024 Financial and Operational Highlights",
      "id": 132560633,
      "image": "",
      "related": "BSX",
      "source": "Finnhub",
      "summary": "Q4 2024 Highlights February 5, 2025 Q4 2024 Financial & Operational Highlights | February 5, 2025 ...",
      "url": "https://finnhub.io/api/news?id=6b78a01feda96b8fc71dad258580033f01de07a54d7dbe6672c0fb6cdf2dbfb0"
    }
  },
  {
    "ts": null,
    "headline": "Walt Disney, Uber, Qualcomm and Arm lead earnings roster",
    "summary": "Walt Disney, Uber, Qualcomm and Arm lead earnings roster",
    "url": "https://finnhub.io/api/news?id=806381216e46a96c948acd40bfbfff0a2159e0274d537544c9540705ba9baff8",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738734420,
      "headline": "Walt Disney, Uber, Qualcomm and Arm lead earnings roster",
      "id": 132565639,
      "image": "",
      "related": "BSX",
      "source": "MarketWatch",
      "summary": "Walt Disney, Uber, Qualcomm and Arm lead earnings roster",
      "url": "https://finnhub.io/api/news?id=806381216e46a96c948acd40bfbfff0a2159e0274d537544c9540705ba9baff8"
    }
  },
  {
    "ts": null,
    "headline": "RenovoRx: From Clinical Promise To Commercial Reality And Trading At A Significant Discount",
    "summary": "RenovoRx's innovative RenovoCath and TAMP platform show promising clinical data. Click here to read why RNXT stock presents an asymmetric opportunity.",
    "url": "https://finnhub.io/api/news?id=cbc5ffbc82a0512bc3f0c22af28a1316e8e9eb15af8f532fbc6d453cf0ac51ff",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738721669,
      "headline": "RenovoRx: From Clinical Promise To Commercial Reality And Trading At A Significant Discount",
      "id": 132559400,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1765288764/image_1765288764.jpg?io=getty-c-w1536",
      "related": "BSX",
      "source": "SeekingAlpha",
      "summary": "RenovoRx's innovative RenovoCath and TAMP platform show promising clinical data. Click here to read why RNXT stock presents an asymmetric opportunity.",
      "url": "https://finnhub.io/api/news?id=cbc5ffbc82a0512bc3f0c22af28a1316e8e9eb15af8f532fbc6d453cf0ac51ff"
    }
  }
]